Dr. Matthew Hamill is interested in the spectrum of STD/HIV: prevention, vaccine development, treatment, and retention in care. His research focuses on rapid, Point-of-Care diagnostics for sexually transmitted infections (STI) in low-income settings.
He provides patient-focused treatment for those with, or at risk of, STI. This encompasses HIV (including Pre Exposure Prophylaxis/PrEP). He is passionate about providing evidence-based, compassionate, high-quality care.
Dr. Hamill is a UK-trained physician, he received his medical degree in 1998 (MB ChB), trained in internal medicine and STD/HIV in London, UK. He spent 3 years conducting research in Soweto, South Africa. Following this, he studied Public Health in the USA.